Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Improved outcome of high risk lymphoblastic leukemia (ALL) with laite high dose therapy.

High dose versus conventional therapy for adult low risk T-ALL and Lymphoblastic lymphoma (LBL).

Comparison between two autograf therapeutic strategies in high risk patients Ramdomised comparison between maintenance treatment with or not interferon alpha 2 a

Inclusion Criteria

• ALL high risk or low risk or lymphoblastic lymphoma
• age 15-55 years old
• informed consent signed

Exclusion Criteria:

• patients previously treated with a chemotherapy or alpha-interferon
• ALL 3 (burkitt like)